NCT05591638

Unknown

Docosahexaenoic Acid Serum Levels in Patients With Preeclamp...

Recep Tayyip Erdogan University Training and Research Hospital Source

Compare

Other study identifiers

Sponsor study identifier

2022/169

Study Type

observational

Estimated enrollment

90

Locations

0 countries

Sites

N/A

Timeline

Study Start

October 24, 2022

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

April 30, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

May 30, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

By comparing the blood levels of docosahexaenoic acid (DHA) in preeclamptic patients with normal pregnant women, we aim to reveal the relationship between these markers, which are known to be effective on metabolic function, and preeclampsia, and to contribute to future studies and possible treatment options

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 90 participants
Study completion date: May 30, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
October 19, 2022
Actual (reported)
First Posted
October 24, 2022
Actual (reported)
Study Start
October 24, 2022
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 30, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 30, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: October 24, 2022
Status Verified: October 2022
Last Update Submitted: October 19, 2022

Conditions

Preeclampsia

Keywords

Preeclampsiadocosahexaenoic acidfatty acidsomega-3

Outcome Measures

Primary Outcomes (1)

docosahexaenoic acid
docosahexaenoic acid levels between groups will be measured
6 months

Study Arms (2)

GROUP 1

There will be 45 patients diagnosed with preeclampsia in the study group

GROUP 2

There will be 45 normal pregnant women in the control group

Eligibility Criteria

Age18 Years - 40 Years

Sexfemale

Age GroupsAdult (18-64)

Sampling MethodNon-Probability Sample

Study Population

18-40 years old pregnant women at 20-40 weeks of gestation with and without preeclampsia (study and control)

You may qualify if:

Pregnant women between the ages of 18-40, singleton pregnancies, pregnant women with preeclampsia, healthy pregnant women who do not have a history of hypertension before and after pregnancy

You may not qualify if:

Sponsors & Collaborators

Recep Tayyip Erdogan University Training and Research Hospital
Otherlead

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

SENOL SENTURK
Recep Tayyip Erdogan University
STUDY DIRECTOR

Central Study Contacts

SENOL SENTURK

CONTACT

+905327166482 dr.senturk@hotmail.com

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate professor

Study Record Dates

First Submitted

October 19, 2022

First Posted

October 24, 2022

Study Start

October 24, 2022

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

April 30, 2023

NCT06481683

Maternal Serum Stathmin-1 Levels in Preeclampsia

Terminated

NCT05564988

Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia

Not ApplicableUnknown

NCT06873737

Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker

Not ApplicableActive Not Recruiting

NCT03838887

Comparison Between Uterine Artery Doppler and Placental Vascular Indices in Prediction of Preeclampsia

Unknown

NCT04699825

Cardiovascular Changes in Infants of Preeclampsia Mother

Not ApplicableUnknown

NCT06315985

Classical Turkish Music for Pregnant Women With Preeclampsia

Not ApplicableUnknown

Pregnant women diagnosed with chronic hypertension before pregnancy, pregnant women with hypertension before the 20th gestational week, multiple pregnancies, pregnant women with molar pregnancies, women with a body mass index (BMI) \>30kg/m2, pregnant women with a history of birth complicated with chromosomal abnormalities, pre-pregnancy or during pregnancy Pregnant women diagnosed with diabetes mellitus, pregnant women diagnosed with chronic systemic diseases, especially rheumatological, renal and vascular diseases, pregnant women diagnosed with chorioamnionitis, pregnant women with polyhydramnios, maternal infection diagnosis

Contact the study team to confirm eligibility.

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

May 30, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

October 24, 2022

Record last verified: 2022-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05591638
Data provider: ClinicalTrials.gov
Source updated: 2022-10-24
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:58 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

GROUP 1

GROUP 2

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record